Thymectomy for non-thymomatous myasthenia gravis: a comparison of surgical methods and analysis of prognostic factors

被引:66
|
作者
Lin, Mong-Wei [1 ]
Chang, Yih-Leong [2 ]
Huang, Pei-Ming [1 ]
Lee, Yung-Chie [1 ]
机构
[1] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Surg, Taipei 10002, Taiwan
[2] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Pathol, Taipei 10002, Taiwan
关键词
Myasthenia gravis; Thymectomy; Video-assisted thoracoscopic surgery; ASSISTED THORACOSCOPIC THYMECTOMY; TRANSSTERNAL THYMECTOMY; AUTOIMMUNE MYASTHENIA; EXTENDED THYMECTOMY; THORACIC-SURGERY; EXPERIENCE; STANDARDS;
D O I
10.1016/j.ejcts.2009.05.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: While thymectomy is an accepted treatment for myasthenia gravis (MG), video-assisted thoracoscopic surgery (VATS) thymectomy has recently become a popular surgical treatment, especially for non-thymomatous MG (NTMG). This study aims to compare the results of VATS thymectomy and trans-sternal thymectomy, and identify prognostic factors in NTMG patients after thymectomy. Methods: A 10-year retrospective review (January 1995 to December 2004) of 60 consecutive thymectomies (22 trans-sternal thymectomies and 38 VATS thymectomies) of NTMG patients performed in a university teaching hospital was undertaken. Results: There were 43 female patients and 17 male patients with a median MG-onset age of 25 years (range: 5-78 years). Median follow-up time was 44 months. VATS thymectomy patients had a shorter hospital stay than the trans-sternal thymectomy patients (5.6 days vs 8.1 days, p = 0.008). There was no other statistically significant difference between the two operative methods in NTMG patients, including intensive care unit (ICU) stay, ventilator support time, operative time, postoperative status, complete stable remission (CSR) rate, morbidity and mortality. Three prognostic factors associated with better remission rate were hyperthyroidism (p = 0.003), age <40 years (p = 0.022) and the presence of thymic hyperplasia (p = 0.041). Other factors, including gender, disease duration, preoperative MG severity, acetylcholine receptor antibody, perioperative therapy and operative methods (32% vs 36%, p = 0.91, 95% confidence interval (CI) = 0.27-3.21) were not statistically relevant to better remission rate. Conclusions: VATS thymectomy is more advantageous for NTMG patients because of shorter hospital stay, less tissue injury, better cosmetic result and equivalent CSR rate. NTMG patients aged <40 years with hyperthyroidism and a histologic diagnosis of lymphofollicular hyperplasia have better chances of remission after thymectomy. (C) 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 50 条
  • [1] Thymectomy for non-thymomatous myasthenia gravis
    Cea, Gabriel
    Benatar, Michael
    Verdugo, Renato J.
    Salinas, Rodrigo A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (10):
  • [2] Comparison of thymomatous and non-thymomatous myasthenia gravis on outcome after thymectomy
    Cabrera-Maqueda, J. M.
    Fuentes Rumi, L.
    Alba Isasi, M. T.
    Vazquez Lorenzo, J.
    Valero Lopez, G.
    Baidez Guerrero, A. E.
    Garcia Molina, E.
    Diaz Perez, J.
    Lopez Sanchez, J.
    Garrnes Sanchez, C. M.
    Arroyo Tristan, A.
    Hernandez Clares, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 258 - 258
  • [3] Thymectomy in thymomatous and non-thymomatous myasthenia gravis: analysis of a cohort of 46 patients
    Cabrera-Maqueda, Jose M.
    Alba-Isasi, M. Teresa
    Hernandez, Rocio
    Arroyo-Tristan, Andres
    Morales-Ortiz, Ana
    REVISTA DE NEUROLOGIA, 2020, 70 (06) : 213 - 219
  • [4] Analysis of outcomes following surgical treatment of thymolipomatous myasthenia gravis: comparison with thymomatous and non-thymomatous myasthenia gravis
    Huang, Chien-Sheng
    Li, Wing-Yin
    Lee, Pei-Chen
    Kao, Ko-Pei
    Chou, Teh-Ying
    Wu, Mei-Han
    Hsu, Han-Shui
    Wu, Yu-Chung
    Hsu, Wen-Hu
    Huang, Biing-Shiun
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2014, 18 (04) : 475 - 481
  • [5] Is thymectomy in non-thymomatous myasthenia gravis of any benefit?
    Diaz, Andres
    Black, Edward
    Dunning, Joel
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2014, 18 (03) : 381 - 389
  • [6] Comparison of thymectomy with conservative treatment in autoimmune non-thymomatous myasthenia gravis
    Emani, Srikanth Reddy
    Taly, Anisya Vasanth
    Taly, Arun B.
    Shankar, S. K.
    JayaKumar, P. N.
    ANNALS OF NEUROLOGY, 2007, 62 : S61 - S61
  • [7] Efficiency of ectopic thymectomy by three surgical approaches in non-thymomatous myasthenia gravis
    Shuishen Zhang
    Zhenguang Chen
    Bin Li
    Chunhua Su
    Haoshuai Zhu
    Beilong Zhong
    Jianyong Zou
    Updates in Surgery, 2022, 74 : 1435 - 1443
  • [8] Outcomes after thymectomy in non-thymomatous myasthenia gravis
    Deboever, Nathaniel
    Xu, Ying
    Feldman, Hope A.
    Woodman, Karin H.
    Chen, Merry
    Shih, Ya-Chen Tina
    Rajaram, Ravi
    JOURNAL OF THORACIC DISEASE, 2023, 15 (06) : 3048 - +
  • [9] DISEASE DURATION AND THYMECTOMY IN NON-THYMOMATOUS MYASTHENIA GRAVIS
    Lyou, Hyun Ji
    Chung, Hye Yoon
    Kim, Seung Woo
    Shin, Ha Young
    MUSCLE & NERVE, 2022, 65 : S15 - S16
  • [10] CERVICAL THYMECTOMY FOR NON-THYMOMATOUS MYASTHENIA-GRAVIS
    WHYTE, RI
    DONNELLY, RJ
    THORAX, 1987, 42 (03) : 226 - 226